Loading…
Lobbying Spend
—
Filings
13
Firms Hired
1
Active Period
2017–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to monitor and address pharmacy and drug pricing-related legislative and regulatory proposals, including, but not limited to, S. 1895, S. 2543 and H.R. 3.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3
Lower Health Care Costs Act
2019 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to monitor and address pharmacy and drug pricing-related legislative and regulatory proposals, including, but not limited to, S. 1895, S. 2543 and H.R. 3.
Client expense: — · Firm income: $30,000
Matched citations: S. 1895
Prescription Drug Pricing Reduction Act of 2019
2019 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to monitor and address pharmacy and drug pricing-related legislative and regulatory proposals, including, but not limited to, S. 1895, S. 2543 and H.R. 3.
Client expense: — · Firm income: $30,000
Matched citations: S. 2543
Elijah E. Cummings Lower Drug Costs Now Act
2019 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to monitor and address pharmacy and drug pricing-related legislative and regulatory proposals, including, but not limited to, S. 1895, S. 2543 and H.R. 3.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3
Lower Health Care Costs Act
2019 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to monitor and address pharmacy and drug pricing-related legislative and regulatory proposals, including, but not limited to, S. 1895, S. 2543 and H.R. 3.
Client expense: — · Firm income: $30,000
Matched citations: S. 1895
Prescription Drug Pricing Reduction Act of 2019
2019 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
Efforts to monitor and address pharmacy and drug pricing-related legislative and regulatory proposals, including, but not limited to, S. 1895, S. 2543 and H.R. 3.
Client expense: — · Firm income: $30,000
Matched citations: S. 2543
Source: Senate LDA